Shionogi & Co., Ltd.

What's New Index

2010/09/01		Shionogi Inc. Press Release: Confirmation of SHIONOGI ANNOUNCES POSITIVE OUTCOME TO THE DECENTRALIZED PROCEDURE FOR THE EUROPEAN APPROVAL OF TWINJECT® (EPINEPHRINE AUTO-INJECTOR)
2010/09/01		Dissolution of a Subsidiary
2010/08/06		Audio Webcasting of Conference Call for the First Quarter of Fiscal Year 2010
2010/08/02		First Quarter of Fiscal Year 2010 Conference Call
2010/08/02		Financial Results for the First Quarter of Fiscal Year 2010
2010/07/30		SHIONOGI INC. ANNOUNCES FDA APPROVAL OF CUVPOSA FOR THE TREATMENT OF CHRONIC SEVERE DROOLING IN PEDIATRIC PATIENTS WITH NEUROLOGIC CONDITIONS
2010/07/23		Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference
2010/07/21		Shionogi-ViiV Healthcare Announces Commitment to Phase III Development Programme for Investigational Once-Daily HIV Integrase Inhibitor
2010/07/01		Shionogi announces reorganization of US Operations, new leadership.
2010/06/30		CRESTOR® PATENT UPHELD BY US DISTRICT COURT, DISTRICT OF DELAWARE
2010/06/17		Establishment of an Organization

Press Release Index

Shionogi & Co., Ltd. has continuously supplied superior pharmaceuticals to people everywhere, based on its company policy to “constantly strive to provide medicine of the best possible kind essential for protection of the health of the people.